Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2020-08-27
DOI
10.1093/ijnp/pyaa068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequency of rehospitalization after hospitalization for suicidal ideation or suicidal behavior in patients with depression
- (2020) M. Soledad Cepeda et al. PSYCHIATRY RESEARCH
- Suicide Ideation and Behavior Assessment Tool (SIBAT): Evaluation of Intra- and Inter-Rater Reliability, Validity, and Mapping to Columbia Classification Algorithm of Suicide Assessment
- (2020) Larry Alphs et al. PSYCHIATRY RESEARCH
- Meta-analysis of suicide rates in the first week and the first month after psychiatric hospitalisation
- (2019) Daniel Chung et al. BMJ Open
- Esketamine for Treatment-Resistant Depression — First FDA-Approved Antidepressant in a New Class
- (2019) Jean Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
- (2018) Carla M. Canuso et al. AMERICAN JOURNAL OF PSYCHIATRY
- Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
- (2018) Markus Dold et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
- (2018) Deborah S. Hasin et al. JAMA Psychiatry
- Comparing factor structures of depressed patients with and without suicidal ideation, a measurement invariance analysis
- (2018) Wouter van Ballegooijen et al. JOURNAL OF AFFECTIVE DISORDERS
- SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM
- (2016) Jorge Lopez-Castroman et al. DEPRESSION AND ANXIETY
- Clinical Characteristics Associated with Suicide Attempts in Clinical Settings: A Comparison of Suicidal and Non-Suicidal Depressed Inpatients
- (2016) Carla Gramaglia et al. Frontiers in Psychiatry
- Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression
- (2014) Andrew F. Leuchter et al. BRITISH JOURNAL OF PSYCHIATRY
- A Model of Placebo Response in Antidepressant Clinical Trials
- (2013) Bret R. Rutherford et al. AMERICAN JOURNAL OF PSYCHIATRY
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- The European Psychiatric Association (EPA) guidance on suicide treatment and prevention
- (2011) D. Wasserman et al. EUROPEAN PSYCHIATRY
- Incidence and Predictors of Suicide Attempts in DSM–IV Major Depressive Disorder: A Five-Year Prospective Study
- (2010) K. Mikael Holma et al. AMERICAN JOURNAL OF PSYCHIATRY
- Development and reliability of a structured interview guide for the Montgomery-Åsberg Depression Rating Scale (SIGMA)
- (2008) Janet B. W. Williams et al. BRITISH JOURNAL OF PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now